Objectives: Although azole antifungals are considered to be fungistatic, miconazole has fungicidal activity against planktonic Candida albicans cells, presumably associated with the induction of reactive oxygen species (ROS) production. Only few data are available concerning the effect of miconazole against sessile C. albicans cells. In the present study, the fungicidal activity of miconazole against in vitro-grown mature Candida biofilms, and its relationship with the induction of ROS and ROS-dependent apoptosis were examined.
Introduction
Candida species are frequently associated with nosocomial infections in immunocompromised hosts. 1 Device-related infections caused by this organism often involve biofilm formation, a process in which planktonic yeast cells adhere to a biotic or abiotic surface, ultimately resulting in the formation of a complex three-dimensional structure of yeast cells, filaments and extracellular polymeric matrix. 2, 3 There are profound differences between planktonic and sessile cells, including an increased tolerance of the latter towards antifungal agents. 4 Azole antifungals are widely used to treat infections with Candida spp. These compounds inhibit the 14a-demethylation of lanosterol by interacting with cytochrome P450, a crucial enzyme in the ergosterol biosynthetic pathway. The resulting decrease in ergosterol levels and the accumulation of toxic sterol intermediates in the cytoplasmic membrane lead to growth inhibition. 5 Miconazole (an imidazole) has reportedly a higher in vitro activity against planktonic Candida albicans cells than the more recently developed and presumably more active fluconazole (a triazole). 6 -8 However, few data are available about the effect of miconazole against Candida biofilms. A fungicidal activity was observed for miconazole against C. albicans biofilms, but only against young (2 -6 h) biofilms. 9 Recent research has shown that the fungicidal activity of miconazole against planktonic C. albicans cells is related to the induction of reactive oxygen species (ROS). Although the exact mechanism of this enhanced ROS accumulation is not completely understood, combined inhibition of catalase and peroxidase, as well as changes in the actin cytoskeleton, appear to be involved. 7, 8 It is well known that antioxidants can act as a reductant for ROS. Antioxidative compounds are important for the prevention of peroxidation and free radical accumulation. 10 Furthermore, ROS are inducers of apoptosis. 11 Programmed cell death was observed in Saccharomyces cerevisiae exposed to different types of oxidative stress. 12, 13 Hyperactivation of the RAS signalling pathway by stabilization of the actin cytoskeleton leads to an increase in cAMP, followed by the loss of the mitochondrial membrane potential and the accumulation of ROS, ultimately leading to apoptosis. 14 Apoptosis is also induced in C. albicans upon treatment with low doses of H 2 O 2 , acetic acid or amphotericin B. 15 The aim of the present study was to investigate the activity of miconazole against Candida biofilms. To this end, the effect of miconazole and fluconazole against mature biofilms of 10 C. albicans strains and 5 strains belonging to other Candida species was compared. ROS levels were determined in miconazole-treated and untreated mature Candida biofilms to verify whether there is a correlation with the activity of miconazole. Finally, we investigated whether increased apoptosis contributes to the antimicrobial effect of miconazole.
Materials and methods

Strains
The following strains were used: C. albicans SC5314 (ATCC MYA-2876) (American Type Culture Collection, Teddington, UK); C. albicans ATCC 10231; C. albicans IHEM 10284 (Institute of Hygiene and Epidemiology-Mycology Section, Brussels, Belgium); C. albicans IHEM 9559; C. albicans NCYC 1467 (National Collection of Yeast Cultures, Norwich, UK); C. albicans MUCL 29800 (Mycothèque de l'Université Catholique de Louvain, Louvain-la-Neuve, Belgium); C. albicans MUCL 29903; C. albicans MUCL 29981; C. albicans MUCL 29919; C. albicans MUCL 30112; Candida dubliniensis IHEM 14280; Candida glabrata MUCL 15664; Candida krusei IHEM 1796; Candida parapsilosis IHEM 3270; and Candida tropicalis IHEM 4225. A stock culture of all these strains was kept in Microbank Tubes (Pro-Lab Diagnostics, Richmond Hill, ON, Canada) at 2808C. Cells were routinely transferred to Sabouraud dextrose agar (SDA) (Oxoid, Basingstoke, UK) plates or Sabouraud dextrose broth (SDB) (Oxoid) and incubated at 378C for 24 h.
Biofilm formation on silicone discs
Candida biofilms were grown on sterile silicone discs (4 mm in thickness and 13 mm in diameter) in a 24-well microtitre plate (TPP, Trasadingen, Switzerland). Silicone sheets were prepared from a medical grade silicone rubber kit (Q7-4735; Dow Corning Corp., Midland, MN, USA), according to the manufacturer's instructions. The discs were punched from the sheets, washed in 2% RBS 35 detergent (Sigma-Aldrich, St Louis, MO, USA) and in MilliQ water (Millipore, Billerica, MA, USA), and autoclaved. Inoculum suspensions were prepared by incubating the cells in SDB for 16 h at 378C. After removing the supernatant, the cells were washed three times with and finally resuspended in 1 mL of 0.9% (w/v) NaCl (Novolab, Geraardsbergen, Belgium). This inoculum was further diluted with yeast nitrogen base 0.1Â(YNB, BD, Franklin Lakes, USA) supplemented with 5 mM glucose (Sigma-Aldrich) to yield an optical density of 0.07 at a wavelength of 600 nm. Then, 1 mL of a 1:100 dilution of the inoculum in YNB 0.1Â was added to each well containing a silicone disc and the 24-well microtitre plates were incubated for 1 h at 378C. Subsequently, the silicone discs were rinsed three times with 1 mL of 0.9% (w/v) NaCl to remove non-adherent cells and aseptically transferred to a new well. Following the addition of 1 mL of diluted YNB (0.004Âwith a final glucose concentration of 0.2 mM) to each well, the plates were further incubated for 24 h at 378C.
Biofilm formation in 96-well microtitre plates
Candida biofilms were grown in round-bottomed 96-well microtitre plates (TPP), as described previously, 16 with an adhesion phase of 1 h followed by a growth phase of 24 h (both at 378C in SDB).
Treatment of biofilms with antifungal agents
The silicone discs containing the mature biofilms were transferred to a new 24-well microtitre plate. Then, 1 mL of a solution of fluconazole (Diflucan, Pfizer, Brussels, Belgium) or miconazole nitrate (Certa, Braine-l'Alleud, Belgium) (final concentration 5 mM, corresponding to 1531 mg/L for fluconazole and 2081 mg/L for miconazole) in PBS with 2% DMSO (Sigma-Aldrich) was added to the biofilms. Appropriate controls were also included. The plates were incubated at 378C for 24 h. The silicone discs were subsequently washed three times with 1 mL of 0.9% (w/v) NaCl. The number of cfu on each silicone disc was determined by pour plating. To this end, the silicone discs with biofilms were transferred to 10 mL of SDB and biofilm cells were removed from the silicone by three cycles of 30 s of sonication and 30 s of vortex mixing. With this procedure, all sessile cells were removed from the silicone discs and clumps of cells were broken apart. 17 Serial 10-fold dilutions of the resulting cell suspension were made, and 1 mL of each dilution was plated and SDA was added, resulting in a lower limit of detection of 10 cfu per disc. Plates were incubated for 24 h at 378C, after which the number of cfu per disc was calculated by counting colonies on the plates. For each strain and treatment, biofilms formed on at least three silicone discs in at least three independent experiments (n! 9) were included.
Detection of ROS
Mature biofilms formed in round-bottomed 96-well microtitre plates were rinsed with 100 mL of 0.9% (w/v) NaCl and treated for 24 h at 378C with 100 mL of a miconazole suspension (5 mM in PBS with 2% DMSO). Appropriate controls were included and incubated under identical conditions. ROS accumulation was measured in a fluorometric assay using 2 0 ,7 0 -dichlorofluorescein diacetate (DCFHDA) (Invitrogen, Carlsbad, CA, USA). 6 To this end, biofilms were incubated with 10 mM DCFHDA, simultaneously with the antifungal treatment. Fluorescence was measured after 24 h of incubation using a Wallac Victor Multilabel Counter (Perkin Elmer, Wellesley, MA, USA) (l EX ¼485 nm; l EM ¼535 nm). The values obtained were corrected for background fluorescence (measured in the absence of cells) and compared with those obtained with untreated biofilms. ROS levels were quantified in duplicate on at least three biofilms (n !6) for each strain. To determine whether fluorescence is generated in the extracellular environment or intracellularly, the entire content of the well (supernatant and biofilm) was removed and cells were separated from the supernatant by centrifugation. The fluorescence of the supernatant and of the resuspended sessile cells in PBS was measured separately, as described above.
Influence of antioxidants on miconazole-treated biofilms
A set of antioxidative compounds was used to investigate their possible protective effect against miconazole activity, including cysteine (0.025% w/v and 0.25% w/v) (Sigma-Aldrich), mannitol (10 and 100 mM) (Merck, Darmstadt, Germany), glutathione (1.5 and 15 mM) (Sigma-Aldrich), ascorbic acid (10 and 100 mM) (Merck) and pyrrolidinedithiocarbamate (PDTC) (10 mM and 1 mM) (Sigma-Aldrich). The level of ROS was determined in miconazole-treated biofilms using DCFHDA (10 mM) in the presence and absence of the antioxidants. The number of cfu on silicone discs of C. albicans SC5314 treated with miconazole in combination with the selected antioxidative compounds was determined by plating in at least three independent experiments on at least three silicone discs for each condition (n! 9).
Antifungal susceptibility assay
The MIC of miconazole in the presence and absence of ascorbic acid (10 mM) was determined according to the protocol of the European Activity of miconazole against sessile Candida cells 695 JAC Committee on Antimicrobial Susceptibility Testing. 18 The medium used for these experiments was RPMI-1640 2Â with L-glutamine and without sodium bicarbonate (Sigma-Aldrich), supplemented with 2% w/v glucose (Sigma-Aldrich) and buffered to pH 7.0 with MOPS (SigmaAldrich). Flat-bottomed 96-well microtitre plates were inoculated with Candida to obtain 5Â10 5 cells/mL in each well. After 24 h of incubation at 358C, the absorbance was measured at a wavelength of 590 nm using a Wallac Victor microtitre plate reader (Perkin Elmer). DCFHDA (10 mM) was also added to each well and the absorbance measurement was immediately followed by a measurement of fluorescence (l EX ¼485 nm; l EM ¼535 nm).
Detection of apoptosis
To investigate a possible apoptosis-inducing effect of miconazole on C. albicans SC5314 biofilms, the Apoptosis Detection Kit Annexin V-CY3 (Sigma-Aldrich) was used. This test allows differentiation between living cells (green fluorescence), necrotic cells (red fluorescence) and apoptotic cells (green and red fluorescence). Biofilms were grown in 96-well microtitre plates and treated with miconazole, as described above. Sessile cells were removed and diluted 1:10 in PBS, after which 50 mL was spotted on a microscope slide and left at room temperature, allowing the cells to be adsorbed to the slide. The adsorbed cells were carefully washed three times with binding buffer (supplied with the apoptosis kit), and treated with a mixture of 6-carboxyfluorescein diacetate (500 mM) and annexin V-Cy3 conjugate (1 mg/L) for 10 min. Excess labelling agent was removed by washing the cells three times with binding buffer. C. albicans biofilms treated with acetic acid (60 and 300 mM) and hydrogen peroxide (5 and 25 mM) were included as positive controls in this assay. Apoptosis in planktonic C. albicans SC5314 cells was also tested. Therefore, overnight cultures were treated with miconazole (10Â MIC) for 24 h and compared with untreated planktonic cultures. The staining procedure was performed as described above for sessile cells. Results were observed using a fluorescence microscope (Olympus BX40, Olympus, Tokyo, Japan). For each condition, between 241 and 1174 cells were photographed, and co-localization of the fluorescein and Cy3 fluorescence signal was quantified on a cell-per-cell basis with an in-house-developed image-processing program based on Matlab to differentiate between living, necrotic and apoptotic cells.
Statistical analysis
Statistical analysis was performed using SPSS 16.0 software. The nonparametric Mann-Whitney test was used to compare the results.
Results
Effect of azoles on Candida biofilms
The effect of fluconazole and miconazole on Candida biofilms formed on silicone discs was determined for 15 strains (Figure 1 ). Untreated biofilms contained 10 5 -10 6 cfu/disc, depending on the strain tested. Treatment with fluconazole did not result in a significant reduction in cfu. In contrast, treatment with miconazole resulted in a substantial reduction (ranging from 89.3% to 99.1%; P,0.05) in the number of cfu recovered from the discs for all strains investigated. The lowest reductions were observed for C. parapsilosis IHEM 3270 (89.3%) and C. tropicalis IHEM 4225 Vandenbosch et al.
(90.3%), and the highest reductions were observed for C. albicans MUCL 30112 (99.1%) and C. albicans IHEM 10284 (99.1%).
Our results showed only a fungistatic effect for fluconazole, whereas miconazole showed fungicidal activity against Candida biofilms.
ROS accumulation in miconazole-treated biofilms
Accumulation of ROS following treatment with miconazole was measured using DCFHDA. As the conversion of this dye depends on the number of metabolically active cells in the biofilm, results were normalized to the number of cfu/disc. Treatment with miconazole resulted in a significant increase in ROS accumulation for all strains investigated (P,0.005) (Figure 2) . No ROS accumulation could be observed for untreated C. dubliniensis IHEM 14280, C. glabrata MUCL 15664 and C. parapsilosis IHEM 3270 biofilms. In contrast, all untreated C. albicans biofilms tested showed a basal ROS accumulation. A remarkably high fluorescence could be observed for C. albicans MUCL 30112. The highest increases (.100-fold) in ROS accumulation after miconazole treatment could be observed for C. albicans MUCL 29919, C. albicans IHEM 9559 and C. albicans MUCL 29800. The lowest impact of miconazole treatment was detected for C. tropicalis IHEM 4225 (2-fold increase) and C. albicans NCYC 1467 (7-fold increase). Measurements were also carried out separately in sessile C. albicans SC5314 cells and in the supernatant. The ROS-induced increase in fluorescence was only observed for the cells and not for the supernatant (data not shown), indicating an intracellular origin.
In conclusion, miconazole caused a significant intracellular increase in ROS accumulation in all Candida strains investigated.
Effect of antioxidants on miconazole-treated biofilms
The effect of the addition of five compounds with antioxidative properties on miconazole-treated C. albicans SC5314 biofilms was investigated using DCFHDA (n! 9 for each treatment). Only cysteine (0.25% w/v), glutathione (15 mM), PDTC (10 mM) and ascorbic acid (10 and 100 mM) significantly reduced (P,0.05) miconazole-induced ROS accumulation (Figure 3) . However, the addition of antioxidants to miconazole-treated biofilms did not result in a statistically significant increase in survival (Figure 3) . Ascorbic acid (10 mM) was selected to further examine the effect of ROS quenchers on other miconazole-treated Candida biofilms. The addition of ascorbic acid did not significantly increase the number of cfu on the silicone discs, but resulted in a reduction of ROS accumulation following treatment with miconazole for all strains tested (Table 1 ). This reduction was statistically significant (P,0.05) when compared with biofilms treated with miconazole alone (n¼ 6 for each strain), except for C. albicans MUCL 29919 and C. glabrata MUCL 15664.
Ascorbic acid reduced the miconazole-induced ROS accumulation in sessile cells, but did not cause an enhanced survival.
Effect of ascorbic acid on the susceptibility of planktonic cells
Miconazole also induced ROS accumulation in planktonic Candida cultures. Addition of ascorbic acid to planktonic cultures incubated with miconazole reduced ROS production (47.8% to 89.9% reduction) for all strains tested (data not shown). The Table 2) . Plate counts correspond to the mean+SEM of at least three independent experiments on at least three silicone discs (n! 9). There was no significant increase in cfu after the addition of ascorbic acid compared with miconazole-treated biofilms without ascorbic acid. Fluorescence results correspond to the mean+SEM of two independent experiments on three biofilms (n¼6). Statistically significant reductions (P,0.05) in ROS accumulation are marked with an asterisk.
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For planktonic cells of most strains, the addition of ascorbic acid reduced the ROS accumulation and the susceptibility to miconazole.
Apoptosis in miconazole-treated planktonic and sessile C. albicans cells
To determine whether the effect of miconazole was due to increased apoptosis, we quantified the number of apoptotic cells in treated and untreated biofilms and planktonic cultures [see Figure S1 , available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)]. Untreated planktonic C. albicans SC5314 cultures contained 14.0%+7.0% apoptotic cells, which was not significantly different from miconazole-treated cells (14.6%+4.5%). In contrast, a slight but not significant increase in the number of necrotic cells could be observed when planktonic cells were treated with miconazole (13.2%+3.6%) compared with untreated cells (7.5%+2.3%). Untreated C. albicans SC5314 biofilms contained 9.7%+4.0% apoptotic cells. A slight increase was observed following treatment with miconazole alone (14.4%+11.5%) or in combination with ascorbic acid (18.5%+6.5%). However, these increases were not significant. In contrast, the fraction of necrotic cells increased significantly (P,0.05) compared with the untreated biofilms (8.9%+3.7%) following treatment with miconazole alone (25.1%+1.9%) or in combination with ascorbic acid (32.7%+8.6%). Low concentrations of acetic acid (60 mM) and hydrogen peroxide (5 mM) resulted in a significant increase (P,0.05) in the fraction of apoptotic cells (34.6%+5.1% and 20.6%+5.2%, respectively). The hydrogen peroxide-treated biofilms also showed a significant increase in the amount of necrotic cells (26.1%+3.5%).
Miconazole did not result in increased apoptosis in planktonic or in sessile Candida cells.
Discussion
In the present study, the antifungal activity of miconazole against Candida biofilms was investigated.
Results from our study showed that miconazole, unlike fluconazole, has a pronounced antibiofilm effect against C. albicans and other Candida spp. It should be noted that the antifungal concentration used in our in vitro experiments (5 mM) was higher than the common therapeutic in vivo concentrations. However, this high concentration is achievable during antifungal lock therapy 19, 20 and allowed us to investigate the mechanism of action of miconazole.
We observed that the accumulation of ROS was strongly increased in sessile Candida cells treated with miconazole, indicating that ROS may be responsible for the fungicidal effect. ROS are generally described as important inducers of apoptosis in yeasts, 10 but ROS induced by treatment with miconazole did not cause an increase in programmed cell death in sessile C. albicans cells. The majority of cells killed by miconazole were necrotic.
The addition of ascorbic acid to miconazole-treated Candida biofilms considerably reduced ROS accumulation for all strains. Surprisingly, this did not lead to a reduction of the fungicidal activity of miconazole. Sessile Candida cells are reportedly more tolerant to oxidative stress than their planktonic counterparts. 21 This inherent tolerance may explain why several antioxidative compounds did not result in an additional protection. Furthermore, previous studies have shown that prior to the induction of ROS miconazole affects the organization of the actin cytoskeleton in yeasts. 8 The coupling of mitochondria to the actin cytoskeleton might lead to an association of actin with channels in the mitochondrial membranes. The opening of these channels is followed by reduction of the membrane potential and, finally, the release of ROS into the cytoplasm. 22 The targeting of the actin cytoskeleton by miconazole may have other effects, which are not counteracted by ascorbic acid. Alternatively, a yet unknown mechanism may contribute to the fungicidal activity of miconazole against sessile Candida cells.
An increase in ROS accumulation caused by miconazole treatment was also observed in all planktonic Candida cultures tested, confirming previous observations in C. albicans. 6, 7 The addition of ascorbic acid to miconazole-treated planktonic Candida cells Activity of miconazole against sessile Candida cells 699 JAC reduced ROS induction for all strains. Furthermore, a simultaneous decrease in susceptibility to miconazole was observed for most strains, which confirmed previous findings concerning the protective effect of antioxidants during miconazole treatment. 6 However, we demonstrated that the protective effect of ascorbic acid was limited in the case of strains with intermediate to high MICs of miconazole.
Our data suggest that miconazole may be useful for the treatment of biofilm-related Candida infections. We have also shown that ROS induction is probably not directly responsible for the reduction in the number of cfu. So far, the basis for the fungicidal activity of miconazole remains unclear and further investigations are needed.
